Pascal and Francis Bibliographic Databases

Help

Permanent link : http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25811857

Export

Selection :

A Phase 1 Study of Weekly Everolimus (RAD001) in Combination With Docetaxel in Patients With Metastatic Breast Cancer

Author
MOULDER, Stacy1 2 ; GLADISH, Gregory3 ; RIVERA, Edgardo1 ; HORTOBAGYI, Gabriel N1 ; TRAN, Hai T5 ; ENSOR, Joe4 ; GONZALEZ-ANGULO, Ana Maria1 ; CRISTOFANILLI, Massimo1 ; MURRAY, James L1 ; BOOSER, Daniel1 ; GIORDANO, Sharon H1 ; BREWSTER, Abeena1 ; MOORE, Julia1
[1] Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
[2] Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
[3] Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
[4] Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
[5] Department of Thoracic Head and Neck Medical Oncology and Pharmacy Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Source

Cancer. 2012, Vol 118, Num 9, pp 2378-2384, 7 p ; ref : 24 ref

CODEN
CANCAR
ISSN
0008-543X
Scientific domain
Medical oncology
Publisher
Wiley-Blackwell, Hoboken, NJ
Publication country
United States
Document type
Article
Language
English
Author keyword
docetaxel everolimus metastatic breast cancer phase 1
Keyword (fr)
Anticancéreux Association médicamenteuse Cancer du sein Cancérologie Docétaxel Essai clinique phase I Evérolimus Homme Métastase Rythme administration Stade avancé Inhibiteur mTOR Antimitotique Cancer Dérivé du taxane Inhibiteur synthèse protéique Lactone Macrolide Pathologie de la glande mammaire Pathologie du sein Tumeur maligne
Keyword (en)
Antineoplastic agent Drug combination Breast cancer Cancerology Docetaxel Phase I trial Everolimus Human Metastasis Administration schedule Advanced stage Antimitotic Cancer Taxane derivatives Protein synthesis inhibitor Lactone Macrolide Mammary gland diseases Breast disease Malignant tumor
Keyword (es)
Anticanceroso Asociación medicamentosa Cáncer del pecho Cancerología Docetaxel Ensayo clínico fase I Everolimus Hombre Metástasis Ritmo administración Estadio avanzado Antimitótico Cáncer Taxane derivado Inhibidor síntesis proteica Lactona Macrólido Glándula mamaria patología Seno patología Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors

Discipline
Gynecology. Andrology. Obstetrics Tumours
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
25811857

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web